Johannah Butler
Payments from drug & device makers
Across 76 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$338
- AstraZeneca$290
- Exact Sciences$147
- Pfizer$115
- Lilly USA, LLC$114
- Abbott$72
- plus $430 from 14 others
What the payments were for
- Food & beverage$1,506100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $338 |
| AstraZeneca | 16 | $290 |
| Exact Sciences | 7 | $147 |
| Pfizer | 6 | $115 |
| Lilly USA, LLC | 6 | $114 |
| Abbott | 3 | $72 |
| Irhythm Technologies, Inc. | 1 | $55 |
| Merck | 2 | $49 |
| Boehringer Ingelheim | 3 | $47 |
| Bayer | 2 | $39 |
| Amgen | 2 | $35 |
| Biogen | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Corcept Therapeutics | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$1,506 in reported general payments places this provider in the 70th percentile of 523 family providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $33,829 |
| Rosuvastatin Calcium | 75 | $1,808 |
| Atorvastatin Calcium | 169 | $1,262 |
| Omeprazole | 77 | $1,144 |
| Gabapentin | 41 | $829 |
| Metoprolol Succinate | 40 | $774 |
| ValacyclovirValacyclovir Hcl | 18 | $679 |
| Pantoprazole Sodium | 38 | $661 |
| Losartan Potassium | 54 | $566 |
| Levothyroxine Sodium | 66 | $556 |
| Mirtazapine | 21 | $517 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $515 |
| Ezetimibe | 12 | $504 |
| Lisinopril | 75 | $488 |
| Sertraline Hcl | 38 | $480 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $115 | $33,82922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 523 family providers in Delaware.
Other family in Lewes
- Taylor HodgesLewes$33K
- Caryn ChasanovLewes$12K
- Alice HoppleLewes$11K
- Sarah RobinsonLewes$8K
- Nina VarugheseLewes$8K
- Ashley HillLewes$6K
- Helen MerrickLewes$5K
- Brandi GreggeMiddletown$110K
- Tracy EstesWilmington$59K
- Kathy GallagherNewark$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.